Targeted Lipid-PEGs
Product Name |
Catalog |
Form |
Unit Size |
Price |
APRPG Mediated Tumor Angiogensis Targeting Lipid Materials |
CDMA079 |
Powder |
20 mg, 50 mg, 100 mg |
INQUIRY
|
DSPE-PEG-A7R(ATWLPPR) |
CDMA056 |
Powder |
20 mg, 50 mg, 100 mg |
INQUIRY
|
DSPE-PEG-anti-CD133 |
CDMA008 |
Powder |
20 mg, 50 mg, 100 mg |
INQUIRY
|
DSPE-PEG-Anti-CD19 mAb |
CDMA005 |
Powder |
20 mg, 50 mg, 100 mg |
INQUIRY
|
DSPE-PEG-Anti-CD20 mAb |
CDMA003 |
Powder |
20 mg, 50 mg, 100 mg |
INQUIRY
|
DSPE-PEG-anti-CD37 mAb |
CDMA014 |
Powder |
20 mg, 50 mg, 100 mg |
INQUIRY
|
DSPE-PEG-Anti-CD44 |
CDMA011 |
Powder |
20 mg, 50 mg, 100 mg |
INQUIRY
|
DSPE-PEG-anti-EGFR scFv C10 |
CDMA022 |
Powder |
20 mg, 50 mg, 100 mg |
INQUIRY
|
DSPE-PEG-Anti-ErbB2 scFv |
CDMA012 |
Powder |
20 mg, 50 mg, 100 mg |
INQUIRY
|
DSPE-PEG-Anti-HER2 Fab’or scFv F5 |
CDMA007 |
Powder |
20 mg, 50 mg, 100 mg |
INQUIRY
|
DSPE-PEG-Anti-HER2 Fab′ |
CDMA020 |
Powder |
20 mg, 50 mg, 100 mg |
INQUIRY
|
DSPE-PEG-Anti-rat CC531mAb |
CDMA030 |
Powder |
20 mg, 50 mg, 100 mg |
INQUIRY
|
DSPE-PEG-Antinucleosome mAb 2C5 |
CDMA009 |
Powder |
20 mg, 50 mg, 100 mg |
INQUIRY
|
DSPE-PEG-ANTPCGPYTHDCPVKR |
CDMA037 |
Powder |
20 mg, 50 mg, 100 mg |
INQUIRY
|
DSPE-PEG-APRPG |
CDMA046 |
Powder |
20 mg, 50 mg, 100 mg |
INQUIRY
|
DSPE-PEG-ATWLPPR |
CDMA055 |
Powder |
20 mg, 50 mg, 100 mg |
INQUIRY
|
DSPE-PEG-c-dGHCitGPQ-c |
CDMA016 |
Powder |
20 mg, 50 mg, 100 mg |
INQUIRY
|
DSPE-PEG-CD19 mAb HD37 |
CDMA001 |
Powder |
20 mg, 50 mg, 100 mg |
INQUIRY
|
DSPE-PEG-CREKA |
CDMA054 |
Powder |
20 mg, 50 mg, 100 mg |
INQUIRY
|
DSPE-PEG-cRGD |
CDMA077 |
Powder |
20 mg, 50 mg, 100 mg |
INQUIRY
|